Hikma Pharmaceuticals slides Monday, underperforms market
Hikma Pharmaceuticals PLC HIK shares slipped 1.68% to £19.86 Monday, on what proved to be an all-around rough trading session ...
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...
Hikma Pharmaceuticals announces Health Canada approval of KLOXXADO nasal spray
Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected ...
Hikma Pharmaceuticals rallies Wednesday, outperforms market
Hikma Pharmaceuticals PLC closed 11.86% below its 52-week high of £23.60, which the company reached on February 13th.